Page 1

Antidiabetics Market share to surpass $110Bn by 2024: Global Market Insights Inc. Antidiabetics Market growth is driven by rising geriatric population base, innovation of new drugs, increasing adoption of drugs and increased disposable income. Owing to the changes in lifestyle, even children between age group of 13-14 years are at high risk to get diabetes. It offers huge opportunities industry players. Antidiabetics Market size is set to reach USD 110 billion by 2024; according to a new research report by Global Market Insights, Inc. Increasing number of obese and diabetic patients coupled with rising patient awareness levels serve as high impact rendering factors for antidiabetic market growth over the forecast period. Favorable government initiatives such as Diabetes Prevention Program (DPP) that aims to help individuals with prediabetes, reduces their risk to develop type 2 diabetes. Trained lifestyle coach works with participants and communicate lifestyle skills, such as, eating healthy food, physical activity and managing stress. Such initiatives should propel industry growth over the forecast period.

Advent of new technologies in products like long acting insulin analogs as well as rapid

acting with increased effectiveness should drive industry growth over the forecast timeframe. The novel insulin pen technology permits low-pain and suitable daily insulin injection that should upsurge therapy sales. Type 2 diabetes mellitus (T2DM) has strong familial aggregation, the person with a parent or sibling with disease are at high risk. People with obesity, hypertension, or dyslipidemia and women with history of gestational diabetes are also at high risk to develop T2DM. Long-acting insulin provide basal insulin coverage. Basal insulin suppresses hepatic gluconeogenesis and prevent increase in glucose level during fasting state in insulindeficient patients. Long acting insulin analog includes insulin glargine (Lantus) and insulin detemir (Levemir) which will drive industry growth.


India Antidiabetics Market, By Product, 2013 - 2024 (USD Million)

Browse key industry insights spread across 130 pages with 55 market data tables & 8 figures & charts from the report Antidiabetics Market in detail along with the table of contents: Biguanides should contribute for significant revenue share in 2016. It is colorless solid and prevents production of glucose in liver. Biguanides are administered orally for the treatment of type 2 diabetes. It helps in improving sensitivity of body towards insulin and decreases amount of sugar absorbed in intestines and will increase demand for such antidiabetic drugs. U.S. antidiabetics market size valued over USD 19.4 billion in 2016 and expected to grow significantly over the coming years. Increased healthcare expenditure along with availability of improved healthcare infrastructure and favorable reimbursement policies should drive antidiabetics market size. UK contributed for significant revenue share in 2016. The growth is attributed due to wide range of funds offered by Diabetes UK for research related to the treatment of diabetes and its complications. In November 2016, the Prime Minister introduced new Diabetes UK office on World Diabetes Day. Japan antidiabetics market should grow at significant rate over the forecast period. Diabetic population is on rise due to lifestyle changes that will accompany economic growth and drive antidiabetic market growth. The Japan Diabetes Society (JDS) encourage progress and development of diabetes study and prevent people from disease in the country. Brazil contributed for significant revenue share. The growth is attributed due to early adoption of insulin analogues and increased use of these products in the country. 2|Page

Some of the companies operating in antidiabetics market include Eli Lilly, Pfizer, Novo Nordisk, Takeda Pharmaceuticals, Sanofi Aventis, Merck, Boehringer Ingelheim and Oramed Pharmaceuticals.

Segmentation of Antidiabetics Market:

Antidiabetics market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2013 to 2024, for the following segments: Antidiabetics market by product o

Insulin o o o o o o


Rapid acting Long acting Premixed insulin Premixed analog Short Acting Intermediate acting

Other o o o o o o o o

Alpha-glucosidase inhibitors Biguanides Sulphonylureas GLP-1 agonist Meglitinides DPP-4 inhibitors SGLT – 2 Thiazolodinediones

Antidiabetics market by application o o

Type I Diabetes Type II & Other

The above information is provided for the following regions and countries: •

North America o U.S. o Canada Europe o Germany o UK o Italy o France o Spain


Asia Pacific o China o India o Japan o Australia Latin America o Brazil o Mexico Middle East and Africa o South Africa o Saudi Arabia

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us: Arun Hegde Corporate Sales, USA Global Market Insights, Inc. Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: Website:


Antidiabetics Market to surpass $110Bn by 2024  

Get more details @ Rising diabetes incidences, large unmet medical needs, and extensive R&D activities to launch new...

Antidiabetics Market to surpass $110Bn by 2024  

Get more details @ Rising diabetes incidences, large unmet medical needs, and extensive R&D activities to launch new...